The University of Oxford has become the first UK academic institution to receive support from the European Medicines Agency's (EMA) PRIority MEdicines (PRIME) scheme for its vaccine targeting the deadly Nipah virus.
Andrew Metcalfe, Biotech Specialist at LumiBio discusses the persistent problem of hospital-acquired infections, and why now is the time to focus on reducing COVID- 19 transmission in clinical settings using the LumiBio solution.
Ruth Smith CEO of Active Care Group and its Christchurch Group division discusses the new highly virulent variant of COVID, vaccinations, and infection prevention and control (IPC).
A new report published in The Lancet investigates why 43% of HIV deaths in 2018 happened in the Black community, with policy solutions for the ongoing HIV epidemic.
Four new research studies looking into Long COVID in the community will receive funding worth £18.5 million from UK Research and Innovation (UKRI) and the National Institute for Health Research (NIHR).
The Pfizer and BioNTech vaccine appears to be significantly less efficient against the South African mutation, but can still stop hosts from experiencing severe COVID and dying from the virus.
A research team at MIT have created a machine-learning strategy to identify existing drugs that could be repurposed to fight COVID-19 in elderly patients.
